Epimedokoreanoside I | 130756-11-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 黄酮类化合物
• 英文名称: Epimedokoreanoside I
• 英文别名: [(2R,3S,4S,5R,6S)-6-[(2S,3R,4S,5S,6S)-5-acetyloxy-3-hydroxy-2-[5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-4-oxo-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-3-yl]oxy-6-methyloxan-4-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl acetate
• CAS: 130756-11-5
• 化学式: C₄₃H₅₄O₂₂
• 分子量: 922.9
• InChiKey: KNAXSPPRLXJPMK-WAFDLGGUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  65
• 可旋转键数：
  16
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  326
• 氢给体数：
  9
• 氢受体数：
  22

文献信息

• COMPOUNDS AND METHODS FOR TREATING ESTROGEN RECEPTOR-RELATED DISEASES
  申请人：Li Jin

  公开号：US20080146658A1

  公开（公告）日：2008-06-19

  Provided herein in certain embodiments are compounds, pharmaceutical compositions and methods for modulating the functions of estrogen receptor alpha 36, for preventing and/or treating diseases related to estrogen receptor alpha 36, for preventing and/or treating respiratory diseases such as asthma, for inducing cell death and/or inhibiting cell proliferation and for preventing and/or treating diseases involving abnormal cell proliferation such as cancers.
• US8252835B2
  申请人：——

  公开号：US8252835B2

  公开（公告）日：2012-08-28